Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir.

Wong, Grace Lai-Hung; Hui, Vicki Wing-Ki; Yip, Terry Cheuk-Fung; Lui, Grace Chung-Yan; Hui, David Shu-Cheong; Wong, Vincent Wai-Sun

Wong, Grace Lai-Hung; Hui, Vicki Wing-Ki; Yip, Terry Cheuk-Fung; Lui, Grace Chung-Yan; Hui, David Shu-Cheong; Wong, Vincent Wai-Sun.

Wong GL; Department of Medicine and Therapeutics, Medical Data Analytics Centre, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong.
Hui VW; Department of Medicine and Therapeutics, Medical Data Analytics Centre, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong.
Yip TC; Department of Medicine and Therapeutics, Medical Data Analytics Centre, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong.
Lui GC; Department of Medicine and Therapeutics, Medical Data Analytics Centre, Stanley Ho Centre for Emerging Infectious Diseases, Chinese University of Hong Kong, Hong Kong.
Hui DS; Department of Medicine and Therapeutics, Medical Data Analytics Centre, Stanley Ho Centre for Emerging Infectious Diseases, Chinese University of Hong Kong, Hong Kong. Electronic address: dschui@cuhk.edu.hk.
Wong VW; Department of Medicine and Therapeutics, Medical Data Analytics Centre, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong. Electronic address: wongv@cuhk.edu.hk.

Gastroenterology ; 2022 Sep 17.

Article in English | MEDLINE | ID: covidwho-2246378

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: J.gastro.2022.09.008

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google